{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:09:46Z","timestamp":1770462586954,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGD24C040007"],"award-info":[{"award-number":["LTGD24C040007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Province Traditional Chinese Medicine Science and Technology Project","award":["2024ZF043"],"award-info":[{"award-number":["2024ZF043"]}]},{"name":"Zhejiang Province Traditional Chinese Medicine Science and Technology Project","award":["2026ZL0088"],"award-info":[{"award-number":["2026ZL0088"]}]},{"name":"Medical Scientific Research Foundation of Zhejiang Province","award":["2024KY932"],"award-info":[{"award-number":["2024KY932"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02620-2","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:32:38Z","timestamp":1767781958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibiting SHP2 improves ventricular remodeling by restoring AMPK phosphorylation and mitochondrial homeostasis"],"prefix":"10.1186","volume":"24","author":[{"given":"Qiao-Juan","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Rou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Zhong","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"2620_CR1","doi-asserted-by":"publisher","first-page":"e2305677","DOI":"10.1002\/advs.202305677","volume":"11","author":"X Shi","year":"2024","unstructured":"Shi X, Dang X, Huang Z, Lu Y, Tong H, Liang F, Zhuang F, Li Y, Cai Z, Huo H, et al. SUMOylation of TEAD1 modulates the mechanism of pathological cardiac hypertrophy. Adv Sci (Weinh). 2024;11:e2305677.","journal-title":"Adv Sci (Weinh)"},{"key":"2620_CR2","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","volume":"43","author":"S Frantz","year":"2022","unstructured":"Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J. 2022;43:2549\u201361.","journal-title":"Eur Heart J"},{"key":"2620_CR3","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/ejhf.1594","volume":"21","author":"NR Jones","year":"2019","unstructured":"Jones NR, Roalfe AK, Adoki I, Hobbs FDR, Taylor CJ. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur J Heart Fail. 2019;21:1306\u201325.","journal-title":"Eur J Heart Fail"},{"key":"2620_CR4","doi-asserted-by":"publisher","first-page":"103576","DOI":"10.1016\/j.redox.2025.103576","volume":"81","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Gong H, Jin L, Liu P, Fan J, Qin X, Zheng Q. Succinate predisposes mice to atrial fibrillation by impairing mitochondrial function via SUCNR1\/AMPK axis. Redox Biol. 2025;81:103576.","journal-title":"Redox Biol"},{"key":"2620_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/CIRCRESAHA.124.325262","volume":"136","author":"X Han","year":"2025","unstructured":"Han X, Shi Q, Tu Y, Zhang J, Wang M, Li W, Liu Y, Zheng R, Wei J, Ye S, et al. Cardiomyocyte PRL2 promotes cardiac hypertrophy via directly dephosphorylating AMPKalpha2. Circ Res. 2025;136:645\u201363.","journal-title":"Circ Res"},{"key":"2620_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41392-021-00542-2","volume":"6","author":"D Wang","year":"2021","unstructured":"Wang D, Yin Y, Wang S, Zhao T, Gong F, Zhao Y, Wang B, Huang Y, Cheng Z, Zhu G, et al. FGF1(DeltaHBS) prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK\/Nur77 suppression. Signal Transduct Target Ther. 2021;6:133.","journal-title":"Signal Transduct Target Ther"},{"key":"2620_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jare.2023.08.015","volume":"61","author":"C Kong","year":"2024","unstructured":"Kong C, Guo Z, Liu F, Tang N, Wang M, Yang D, Li C, Yang Z, Ma Y, Wang P, Tang Q. Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy. J Adv Res. 2024;61:65\u201381.","journal-title":"J Adv Res"},{"key":"2620_CR8","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","volume":"146","author":"L Jin","year":"2022","unstructured":"Jin L, Geng L, Ying L, Shu L, Ye K, Yang R, Liu Y, Wang Y, Cai Y, Jiang X, et al. FGF21-Sirtuin 3 axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity. Circulation. 2022;146:1537\u201357.","journal-title":"Circulation"},{"key":"2620_CR9","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-017-02351-0","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo W, Liu W, Chen Z, Gu Y, Peng S, Shen L, Shen Y, Wang X, Feng GS, Sun Y, Xu Q. Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis. Nat Commun. 2017;8:2168.","journal-title":"Nat Commun"},{"key":"2620_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","volume":"117","author":"A Alonso","year":"2004","unstructured":"Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. Protein tyrosine phosphatases in the human genome. Cell. 2004;117:699\u2013711.","journal-title":"Cell"},{"key":"2620_CR11","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1126\/science.8096088","volume":"259","author":"GS Feng","year":"1993","unstructured":"Feng GS, Hui CC, Pawson T. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science. 1993;259:1607\u201311.","journal-title":"Science"},{"key":"2620_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcdb.2014.09.013","volume":"37","author":"J Lauriol","year":"2015","unstructured":"Lauriol J, Jaffre F, Kontaridis MI. The role of the protein tyrosine phosphatase SHP2 in cardiac development and disease. Semin Cell Dev Biol. 2015;37:73\u201381.","journal-title":"Semin Cell Dev Biol"},{"key":"2620_CR13","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1172\/JCI87037","volume":"126","author":"J Wang","year":"2016","unstructured":"Wang J, Mizui M, Zeng LF, Bronson R, Finnell M, Terhorst C, Kyttaris VC, Tsokos GC, Zhang ZY, Kontaridis MI. Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus. J Clin Invest. 2016;126:2077\u201392.","journal-title":"J Clin Invest"},{"key":"2620_CR14","doi-asserted-by":"crossref","unstructured":"Garcia Barbera F, Picech F, Cecenarro L, Mezger GF, Faure E, Zlocowski N, Calafat P, De Battista JC, Mukdsi JH, Sosa LDV, Petiti JP. SHP2 Inhibition reduces somatotroph tumor growth in a pre-clinical model. Neuro Oncol. 2025;27(7):1702\u201314.","DOI":"10.1093\/neuonc\/noaf057"},{"key":"2620_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/db23-0700","volume":"73","author":"X Han","year":"2024","unstructured":"Han X, Wei J, Zheng R, Tu Y, Wang M, Chen L, Xu Z, Zheng L, Zheng C, Shi Q, et al. Macrophage SHP2 deficiency alleviates diabetic nephropathy via suppression of MAPK\/NF-kappaB- dependent inflammation. Diabetes. 2024;73:780\u201396.","journal-title":"Diabetes"},{"key":"2620_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465\u20138.","journal-title":"Nat Genet"},{"key":"2620_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcdb.2014.09.013","volume":"37","author":"J Lauriol","year":"2015","unstructured":"Lauriol J, Jaffr\u00e9 F, Kontaridis MI. The role of the protein tyrosine phosphatase SHP2 in cardiac development and disease. Semin Cell Dev Biol. 2015;37:73\u201381.","journal-title":"Semin Cell Dev Biol"},{"key":"2620_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","volume":"132","author":"B Ye","year":"2023","unstructured":"Ye B, Zhou H, Chen Y, Luo W, Lin W, Zhao Y, Han J, Han X, Huang W, Wu G, et al. USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circ Res. 2023;132:465\u201380.","journal-title":"Circ Res"},{"key":"2620_CR19","doi-asserted-by":"crossref","unstructured":"Zhang P, Lu H, Wu Y, Lu D, Li C, Yang X, Chen Z, Qian J, Ge J. COX5A alleviates Doxorubicin-Induced cardiotoxicity by suppressing oxidative Stress, mitochondrial dysfunction and cardiomyocyte apoptosis. Int J Mol Sci .2023;24(12):10400.","DOI":"10.3390\/ijms241210400"},{"key":"2620_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nature18621","volume":"535","author":"YN Chen","year":"2016","unstructured":"Chen YN, LaMarche MJ, Chan HM, Fekkes P, Garcia-Fortanet J, Acker MG, Antonakos B, Chen CH, Chen Z, Cooke VG, et al. Allosteric Inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature. 2016;535:148\u201352.","journal-title":"Nature"},{"key":"2620_CR21","doi-asserted-by":"crossref","unstructured":"Vlimmeren AEV, Voleti R, Chartier CA, Jiang ZY, Karandur D, Humphries PA, Lo WL, Shah NH. The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N- terminal regulatory domain. Proc Natl Acad Sci USA. 2024;121(30):e2407159121.","DOI":"10.1073\/pnas.2407159121"},{"key":"2620_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19:121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2620_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","volume":"27","author":"SC Lin","year":"2018","unstructured":"Lin SC, Hardie DG. AMPK: sensing glucose as well as cellular energy status. Cell Metabol. 2018;27:299\u2013313.","journal-title":"Cell Metabol"},{"key":"2620_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Reviews Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Reviews Cardiol"},{"key":"2620_CR25","doi-asserted-by":"crossref","unstructured":"G\u00e9linas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, Daskalopoulos EP, Esfahani H, Dubois-Deruy E, Lauzier B et al. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation. Nat Commun. 2018;9(1):374.","DOI":"10.1038\/s41467-017-02795-4"},{"key":"2620_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/CIRCULATIONAHA.123.067519","volume":"150","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Gu J, Niu X, Hu J, Zhang Y, Li D, Tang Y, Liu C, Li Z. Phosphorylation-Regulated dynamic phase separation of HIP-55 protects against heart failure. Circulation. 2024;150:938\u201351.","journal-title":"Circulation"},{"key":"2620_CR27","doi-asserted-by":"publisher","first-page":"102467","DOI":"10.1016\/j.arr.2024.102467","volume":"100","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang Y, Li H, Wang DW, Chen C. Insights into the post-translational modifications in heart failure. Ageing Res Rev. 2024;100:102467.","journal-title":"Ageing Res Rev"},{"key":"2620_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00395-016-0536-7","volume":"111","author":"CY Li","year":"2016","unstructured":"Li CY, Zhou Q, Yang LC, Chen YH, Hou JW, Guo K, Wang YP, Li YG. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK\/-JNK1\/2 signaling pathway. Basic Res Cardiol. 2016;111:19.","journal-title":"Basic Res Cardiol"},{"key":"2620_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/cvr\/cvw101","volume":"111","author":"R Gogiraju","year":"2016","unstructured":"Gogiraju R, Schroeter MR, Bochenek ML, Hubert A, M\u00fcnzel T, Hasenfuss G, Sch\u00e4fer K. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice. Cardiovasc Res. 2016;111:204\u201316.","journal-title":"Cardiovasc Res"},{"key":"2620_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","volume":"28","author":"BG Neel","year":"2003","unstructured":"Neel BG, Gu H, Pao L. The \u2018Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003;28:284\u201393.","journal-title":"Trends Biochem Sci"},{"key":"2620_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/excr.1999.4668","volume":"253","author":"GS Feng","year":"1999","unstructured":"Feng GS. Shp-2 tyrosine phosphatase: signaling one cell or many. Exp Cell Res. 1999;253:47\u201354.","journal-title":"Exp Cell Res"},{"key":"2620_CR32","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1128\/MCB.24.12.5340-5352.2004","volume":"24","author":"MI Kontaridis","year":"2004","unstructured":"Kontaridis MI, Eminaga S, Fornaro M, Zito CI, Sordella R, Settleman J, Bennett AM. SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway. Mol Cell Biol. 2004;24:5340\u201352.","journal-title":"Mol Cell Biol"},{"key":"2620_CR33","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1128\/MCB.22.12.4062-4072.2002","volume":"22","author":"SQ Zhang","year":"2002","unstructured":"Zhang SQ, Tsiaras WG, Araki T, Wen G, Minichiello L, Klein R, Neel BG. Receptor-specific regulation of phosphatidylinositol 3\u2019-kinase activation by the protein tyrosine phosphatase Shp2. Mol Cell Biol. 2002;22:4062\u201372.","journal-title":"Mol Cell Biol"},{"key":"2620_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/13543776.2024.2365410","volume":"34","author":"A Petrocchi","year":"2024","unstructured":"Petrocchi A, Ciammaichella A. A patent review of SHP2 allosteric inhibitors (2018-present). Expert Opin Ther Pat. 2024;34:383\u201396.","journal-title":"Expert Opin Ther Pat"},{"key":"2620_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1158\/2159-8290.CD-21-0369","volume":"12","author":"KH Tang","year":"2022","unstructured":"Tang KH, Li S, Khodadadi-Jamayran A, Jen J, Han H, Guidry K, Chen T, Hao Y, Fedele C, Zebala JA, et al. Combined Inhibition of SHP2 and CXCR1\/2 promotes antitumor T-cell response in NSCLC. Cancer Discov. 2022;12:47\u201361.","journal-title":"Cancer Discov"},{"key":"2620_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.apsb.2020.07.010","volume":"11","author":"Z Song","year":"2021","unstructured":"Song Z, Wang M, Ge Y, Chen XP, Xu Z, Sun Y, Xiong XF. Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. Acta Pharm Sin B. 2021;11:13\u201329.","journal-title":"Acta Pharm Sin B"},{"key":"2620_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","volume":"18","author":"GR Steinberg","year":"2019","unstructured":"Steinberg GR, Carling D. AMP-activated protein kinase: the current landscape for drug development. Nat Rev Drug Discov. 2019;18:527\u201351.","journal-title":"Nat Rev Drug Discov"},{"key":"2620_CR38","doi-asserted-by":"publisher","first-page":"113614","DOI":"10.1016\/j.yexcr.2023.113614","volume":"428","author":"A Sharma","year":"2023","unstructured":"Sharma A, Anand SK, Singh N, Dwivedi UN, Kakkar P. AMP-activated protein kinase: an energy sensor and survival mechanism in the reinstatement of metabolic homeostasis. Exp Cell Res. 2023;428:113614.","journal-title":"Exp Cell Res"},{"key":"2620_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, Zhang C, Liu D, Zheng M, Gao J. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9:124.","journal-title":"Signal Transduct Target Ther"},{"key":"2620_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","volume":"135","author":"A Hinton Jr","year":"2024","unstructured":"Hinton A Jr., Claypool SM, Neikirk K, Senoo N, Wanjalla CN, Kirabo A, Williams CR. Mitochondrial structure and function in human heart failure. Circ Res. 2024;135:372\u201396.","journal-title":"Circ Res"},{"key":"2620_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","volume":"145","author":"L Zhuang","year":"2022","unstructured":"Zhuang L, Jia K, Chen C, Li Z, Zhao J, Hu J, Zhang H, Fan Q, Huang C, Xie H, et al. DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics. Circulation. 2022;145:829\u201346.","journal-title":"Circulation"},{"key":"2620_CR42","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1038\/s41467-024-48970-2","volume":"15","author":"YL Ma","year":"2024","unstructured":"Ma YL, Kong CY, Guo Z, Wang MY, Wang P, Liu FY, Yang D, Yang Z, Tang QZ. Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5\/NR4a1 axis. Nat Commun. 2024;15:4757.","journal-title":"Nat Commun"},{"key":"2620_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yjmcc.2024.04.011","volume":"191","author":"A Choksey","year":"2024","unstructured":"Choksey A, Carter RD, Thackray BD, Ball V, Kennedy BWC, Ha LHT, Sharma E, Broxholme J, Castro-Guarda M, Murphy MP, et al. AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats. J Mol Cell Cardiol. 2024;191:12\u201322.","journal-title":"J Mol Cell Cardiol"},{"key":"2620_CR44","doi-asserted-by":"publisher","first-page":"H749","DOI":"10.1152\/ajpheart.00414.2014","volume":"308","author":"G Barreto-Torres","year":"2015","unstructured":"Barreto-Torres G, Hernandez JS, Jang S, Rodr\u00edguez-Mu\u00f1oz AR, Torres-Ramos CA, Basnakian AG, Javadov S. The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPAR\u03b1-cyclophilin D interaction in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2015;308:H749\u2013758.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2620_CR45","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","volume":"119","author":"H Sasaki","year":"2009","unstructured":"Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, et al. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation. 2009;119:2568\u201377.","journal-title":"Circulation"},{"key":"2620_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","volume":"18","author":"JA Amorim","year":"2022","unstructured":"Amorim JA, Coppotelli G, Rolo AP, Palmeira CM, Ross JM, Sinclair DA. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat Rev Endocrinol. 2022;18:243\u201358.","journal-title":"Nat Rev Endocrinol"},{"key":"2620_CR47","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.119.042791","volume":"140","author":"D Kula-Alwar","year":"2019","unstructured":"Kula-Alwar D, Prag HA, Krieg T. Targeting succinate metabolism in Ischemia\/Reperfusion injury. Circulation. 2019;140:1968\u201370.","journal-title":"Circulation"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02620-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:03:07Z","timestamp":1770397387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02620-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2620"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02620-2","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}